Skip to main content
. Author manuscript; available in PMC: 2013 Aug 14.
Published in final edited form as: Arch Gen Psychiatry. 2011 Jan 3;68(5):516–526. doi: 10.1001/archgenpsychiatry.2010.190

Table 1.

General Baseline Characteristics

Characteristic Both Groups (n=22) Varenicline Group (n=11) Placebo Group (n=11) P Value
Male sex, No. 16 9 7
Race, No.
 African American 7 5 2
 European American 14 5 9
 Mixed 1 1 0
Handedness,a No.
 Right 18 9 9
 Left 3 2 1
 Both 1 0 1
Age, mean (SEM), y 36.1 (2.2) 37.9 (3.4) 34.4 (2.9) .44
Education, mean (SEM), y 14.2 (0.4) 14.4 (0.6) 14.1 (0.6) .74
Cigarettes smoked per day, mean (SEM) [range], No.
 At start of study 17.5 (1.6) [6–30] 19.1 (2.4) [6–30] 15.8 (2.0) [9–20] .31
 At end of study 11.9 (1.6) [1–30] 11.8 (2.6) [2–30] 12.0 (2.0) [1–24] .96
Pack yearsb 12.6 (2.1) 16.4 (3.5) 8.7 (1.9) .07
FTND score 4.7 (0.4) 5.1 (0.7) 4.3 (0.3) .31
Desire to quit,c % 86.3 85.5 87.2 .84

Abbreviation: FTND, Fagerstrom Test for Nicotine Dependence.

a

As assessed by the Edinburgh Handedness Inventory.

b

Calculated as the number of cigarettes smoked per day divided by number of cigarettes in a pack multiplied by the number of years smoking.

c

Assessed by asking subjects to rate their agreement with the phrase “I want to quit smoking.” Scores ranged from 0 to 100, where 0 indicates strongly disagree and 100 indicates strongly agree.